Continuous Manufacturing: From Innovation to Regulatory Reality
This session explored how pharma teams adopt continuous manufacturing using digital technologies and real-time monitoring, highlighting how FDA ETP enables compliant innovation.
Continuous Manufacturing in Regulated Environments
Continuous manufacturing is transforming API production across development and commercial stages. This session highlighted how these systems operate within GxP frameworks, integrating quality, validation, and traceability to meet regulatory expectations.
Real-World Implementation
The discussion focused on practical challenges including scalability, technology adoption, and regulatory alignment. It showcased how ETP engagement helps move from pilot setups to production-ready systems supporting compliance and quality.
Event at a Glance
177+
Registrations
47+
Unique viewers
1835
Minutes viewed
Featured Voices
Visionaries who led the conversation.
Nagesh Nama
Chief Executive Officer, xLM
John Raech
President, Pharma Resource Group (PRG)
60 Minutes ofPractical Insight
April 23, 2026
Full access session recording available on demand.
60 Minutes of Content
Focused discussion on continuous manufacturing, FDA ETP, and AI-driven pharma operations.
This LinkedIn Live session brought together industry leaders to explore how pharmaceutical organizations are adopting continuous manufacturing, advanced analytics, and digital-first approaches in alignment with the FDA’s Emerging Technology Program (ETP). Through PRG’s real-world journey, the discussion highlighted how early regulatory engagement, real-time process monitoring, and AI-driven quality insights can reduce risk, accelerate innovation, and build inspection-ready operations from the ground up.
Detailed Event Overview
This LinkedIn Live session explored how pharmaceutical organizations are advancing toward continuous manufacturing through digital technologies, real-time analytics, and AI-driven processes. Centered on PRG’s journey, it highlighted how early FDA ETP engagement helps navigate regulatory expectations while accelerating innovation and building inspection-ready operations.
FDA ETP & Manufacturing Innovation
Learn why FDA Emerging Technology Program participation can support innovation and accelerate the adoption of advanced manufacturing approaches.
Continuous Manufacturing Readiness
Explore the operational, technical, and regulatory considerations required to successfully implement continuous manufacturing systems.
Regulatory Alignment & Compliance
Understand how organizations can balance innovation with regulatory expectations while maintaining compliance and inspection readiness.
Digital Monitoring & Process Visibility
Discover how real-time monitoring, analytics, and connected technologies enhance process control, quality oversight, and operational performance.